GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Ai Xin'an® (China) | SHR-1209 | SHR1209
recaticimab is an approved drug
Compound class:
Antibody
Comment: Recaticimab (SHR-1209) is an anti-proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibody.
|
| Bioactivity Comments |
| We have been unable to find a published, quantitative affinity value for recaticimab at its molecular target PCSK9. |
| Selectivity at enzymes | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
